1、Growth Equity in European HealthtechJune 2024Page/2 Pan-European growth investor focused on the Healthtech sector.MTIP is a leading Swiss-based growth equity firm investing in European healthtech companies that aim to revolutionize global healthcare.MTIP Fund II and future funds are classified as Ar

2、ticle 9 funds*.Thus,we are driven to empower innovations with the potential to transform lives and create a meaningful impact on the world.As the healthcare landscape evolves towards digitally connected,decentralized,and patient-centric solutions,MTIP is dedicated to investing in European digital ca

3、re,digital pharma,and health IT companies.Global startup&venture capital intelligence platformDealroom.co is the foremost data provider on startup,early-stage and growth company ecosystems in Europe and around the globe.Founded in Amsterdam in 2013,we now work with many of the worlds most prominent

4、investors,entrepreneurs and government organizations to provide transparency,analysis and insights on venture capital activity.*Article 9 funds are targeting social investments to deliver strong financial as well as social impact.Page/3 Emerging trends-Medical ImagingIn 2023,European imaging startup

5、s raised$311 million,half of which came from AI-powered solutions.Despite a dip in AI funding,the sector continues to grow.ForewordMTIP quote introducing report on state european growth stage healthtech(mention of specific rounds,investors,key trends or other)-Healthtech startups have seen growth ov

6、er the past 10 years,currently,the innovations that reached the market 10 years ago are in the growth stage.At MTIP,we support that growth-the Healthtech sector has shown maturation and increased investor confidence as these companies demonstrate product-market fit and commercial traction-This trend